Introdução

Esta página fornece uma análise abrangente do histórico conhecido de negociações internas de Gary L Crocker. Insiders são oficiais, diretores ou investidores significativos em uma empresa. É ilegal para insiders realizarem negociações em suas próprias empresas baseados em informações específicas, não públicas. Isso não significa que seja ilegal para eles realizarem qualquer negociação em suas próprias empresas. No entanto, eles devem reportar todas as negociações à SEC através de um Formulário 4. Apesar dessas restrições, pesquisas acadêmicas sugerem que insiders - em geral - tendem a superar o mercado em suas próprias empresas.

Rentabilidade Média de Negociação

A rentabilidade média de negociação é o retorno médio de todas as compras de mercado abertas feitas pelo insider nos últimos três anos. Para calcular isso, examinamos cada compra de mercado aberto, não planejada, feita pelo insider, excluindo todas as negociações que foram marcadas como parte de um plano de negociação 10b5-1. Em seguida, calculamos o desempenho médio dessas negociações ao longo de 3, 6 e 12 meses, fazendo a média de cada uma dessas durações para gerar uma métrica de desempenho final para cada negociação. Finalmente, fazemos a média de todas as métricas de desempenho para calcular uma métrica de desempenho para o insider. Esta lista inclui apenas insiders que fizeram pelo menos três negociações nos últimos dois anos.

Se a rentabilidade de negociação deste insider é "N/A", então o insider ou não fez quaisquer compras de mercado aberto nos últimos três anos, ou as negociações que eles fizeram são muito recentes para calcular uma métrica de desempenho confiável.

Frequência de Atualização: Diariamente

Veja a lista dos negociantes internos mais rentáveis.

Empresas com Posições Internas Reportadas

As declarações à SEC indicam que Gary L Crocker reportou posses ou negociações nas seguintes empresas:

Ativo Título Últimas Posições Reportadas
US:MACK / Merrimack Pharmaceuticals, Inc. See Remarks, Director 133,105
Como Interpretar os Gráficos

Os gráficos a seguir mostram o desempenho das ações dos a ativos ubsequentes a cada transação de mercado aberto, não planejada feita por Gary L Crocker. Transações não planejadas são negociações que não foram feitas como parte de um plano de negociação 10b5-1. O desempenho das ações é representado como mudança percentual cumulativa no preço das ações. Por exemplo, se uma transação interna foi feita em 1 de janeiro de 2019, o gráfico mostrará a mudança percentual diária da segurança até o dia presente. Se o preço da ação passasse de $10 para $15 durante este período, a mudança percentual cumulativa no preço das ações seria de 50%. Uma mudança no preço de $10 para $20 seria de 100%, e uma mudança no preço de $10 para $5 seria de -50%.

Ultimamente, estamos tentando determinar quão estreitamente as negociações do interno correlacionam-se a retornos excessivos (positivos ou negativos) no preço da ação para ver se o interno está cronometrando suas transações para lucrar com informações internas. Considere a situação onde um interno estava fazendo isso. Nesta situação, esperaríamos (a) retornos positivos após compras, ou (b) retornos negativos após vendas. No caso de (a), o gráfico de COMPRA mostraria uma série de curvas ascendentes, indicando retornos positivos após cada transação de compra. No caso de (b), o gráfico de VENDA mostraria uma série de curvas descendentes, indicando retornos negativos após cada transação de venda.

No entanto, isso sozinho não é suficiente para tirar conclusões. Se, por exemplo, o preço da ação da empresa estivesse em uma escalada não cíclica ao longo de muitos anos, então esperaríamos que todos os gráficos pós-compra tivessem uma inclinação ascendente. Da mesma forma, declínios não cíclicos ao longo de muitos anos resultariam em gráficos pós-negociação inclinados para baixo. Nenhum desses gráficos sugeriria atividade de negociação interna.

O indicador mais forte seria uma situação em que o preço da ação fosse extremamente cíclico, e houvesse sinais positivos no gráfico de COMPRA e gráficos negativos no gráfico de VENDA. Esta situação seria altamente sugestiva de um interno que estava cronometrando transações para sua vantagem financeira.

Histórico de Negociações Insider

Esta tabela mostra a lista completa de negociações insider realizadas por Gary L Crocker conforme divulgadas para a Comissão de Valores Mobiliários (SEC).

Data do Arquivo Data da Transação Formulário Ticker Ativo Código 10b5-1 Ações Ações Restantes Variação
Percentual
Preço
da Ação
Valor
da Transação
Valor
Restante
2023-08-14 2023-08-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2,000 133,105 1.53 12.43 24,865 1,654,841
2023-08-14 2023-08-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2,000 133,105 1.53 12.52 25,039 1,666,421
2022-06-13 2022-06-09 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4,452 131,105 3.52 5.15 22,918 674,902
2022-06-09 2022-06-08 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 349 126,653 0.28 5.14 1,795 651,452
2022-06-09 2022-06-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 300 126,304 0.24 5.05 1,515 637,835
2022-05-26 2022-05-25 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 132 126,004 0.10 5.13 678 647,005
2022-05-26 2022-05-24 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2,323 125,872 1.88 5.09 11,817 640,298
2022-05-23 2022-05-19 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 512 123,549 0.42 5.04 2,582 623,033
2022-05-19 2022-05-18 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 123,037 4.24 5.08 25,407 625,200
2022-05-19 2022-05-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 225 118,037 0.19 5.10 1,147 601,469
2022-05-16 2022-05-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3 117,812 0.00 4.90 15 577,279
2022-05-16 2022-05-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2,471 117,809 2.14 5.04 12,456 593,863
2022-04-25 2022-04-21 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 115,338 4.53 6.00 30,001 692,051
2022-04-01 2022-03-31 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 300 110,338 0.27 6.18 1,853 681,525
2022-04-01 2022-03-30 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 161 110,038 0.15 6.20 998 682,236
2022-03-29 2022-03-28 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 109,877 4.77 6.16 30,822 677,315
2022-03-24 2022-03-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 400 104,877 0.38 6.11 2,446 641,197
2022-03-17 2022-03-15 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4,649 104,477 4.66 6.14 28,556 641,729
2022-03-15 2022-03-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 99,828 5.27 6.02 30,120 601,374
2022-03-15 2022-03-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 94,828 5.57 6.08 30,406 576,678
2022-02-23 2022-02-18 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3,351 89,828 3.88 5.96 19,970 535,312
2022-02-18 2022-02-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 86,477 6.14 6.13 30,626 529,689
2022-02-18 2022-02-16 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 7,945 81,477 10.80 6.20 49,231 504,872
2022-02-16 2022-02-15 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 123 73,532 0.17 6.20 763 455,898
2022-02-16 2022-02-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1,800 73,409 2.51 5.96 10,724 437,341
2022-01-31 2022-01-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 673 71,609 0.95 4.60 3,096 329,401
2022-01-27 2022-01-26 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3,100 70,936 4.57 4.56 14,121 323,128
2022-01-25 2022-01-24 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 7,105 67,836 11.70 4.33 30,741 293,506
2022-01-25 2022-01-21 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2,000 60,731 3.41 4.65 9,310 282,691
2022-01-20 2022-01-18 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 58,731 9.31 4.54 22,690 266,515
2022-01-18 2022-01-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 53,731 10.26 4.51 22,554 242,364
2022-01-18 2022-01-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 48,731 11.43 4.42 22,120 215,591
2022-01-13 2022-01-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 43,731 12.91 4.33 21,658 189,425
2022-01-13 2022-01-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 38,731 14.82 4.03 20,140 156,012
2021-06-14 2021-06-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8,000 8,000
2021-04-14 2021-04-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 973 33,731 2.97 6.07 5,905 204,713
2021-04-12 2021-04-09 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1,200 32,758 3.80 6.10 7,320 199,824
2021-04-09 2021-04-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 2,127 31,558 7.23 6.19 13,166 195,344
2021-04-01 2021-03-31 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 500 29,431 1.73 6.19 3,094 182,148
2021-03-26 2021-03-25 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 200 28,931 0.70 6.13 1,226 177,347
2021-03-25 2021-03-24 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 28,731 21.07 6.34 31,690 182,097
2021-03-25 2021-03-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3,627 23,731 18.04 6.47 23,455 153,461
2021-03-17 2021-03-16 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 20,104 33.10 6.79 33,956 136,530
2021-03-05 2021-02-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 15,104 49.49 7.20 36,004 108,762
2021-02-17 2021-02-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,000 10,104 97.96 7.47 37,342 75,461
2021-02-12 2021-02-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 1,604 5,104 45.83 7.98 12,798 40,722
2021-02-12 2021-02-10 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3,500 3,500 7.64 26,757 26,757
2020-08-03 2020-07-30 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8,000 8,000
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -6,228 0 -100.00 3.20 -19,942
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -17,250 0 -100.00 3.20 -55,234
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -52,068 0 -100.00 3.04 -158,386
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -86,549 0 -100.00 3.04 -263,273
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -8,428 0 -100.00 3.20 -26,986
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -5,986 0 -100.00 3.04 -18,209
2020-07-24 2020-07-22 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
S - Sale -17,000 0 -100.00 3.20 -54,434
2019-10-21 2019-10-17 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8,000 8,000
2018-06-15 2018-06-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8,000 8,000
2017-09-15 2017-09-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 8,625 8,625
2016-06-16 2016-06-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 49,500 49,500
2015-05-18 2015-05-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 17,500 17,500
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -50,000 0 -100.00
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -35,000 0 -100.00
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 50,000 2,943,961 1.73 2.47 123,500 7,271,584
2015-04-10 2015-04-02 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 35,000 2,893,961 1.22 1.71 59,850 4,948,673
2014-11-14 2014-11-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 8,630 2,858,961 0.30 8.37 72,233 23,929,504
2014-11-14 2014-11-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 5,760 2,850,331 0.20 8.62 49,651 24,569,853
2014-06-24 2014-06-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 36,000 2,844,571 1.28 6.84 246,240 19,456,866
2014-05-22 2014-05-20 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4,000 2,808,571 0.14 6.69 26,760 18,789,340
2014-05-20 2014-05-19 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 6,000 2,804,571 0.21 6.71 40,260 18,818,671
2014-05-20 2014-05-16 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 3,400 2,798,571 0.12 6.63 22,542 18,554,526
2014-05-15 2014-05-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 37,834 37,834
2014-05-08 2014-05-07 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 4,400 2,795,171 0.16 6.77 29,788 18,923,308
2014-05-07 2014-05-06 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 7,500 2,790,771 0.27 6.85 51,375 19,116,781
2014-05-07 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10,000 2,783,271 0.36 6.92 69,200 19,260,235
2014-05-06 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -35,000 0 -100.00
2014-05-06 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 35,000 2,773,271 1.28 1.25 43,750 3,466,589
2014-05-06 2014-05-05 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 10,000 2,738,271 0.37 6.69 66,900 18,319,033
2014-03-14 2014-03-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -50,000 0 -100.00
2014-03-14 2014-03-12 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
M - Exercise 50,000 2,728,271 1.87 1.25 62,500 3,410,339
2013-12-02 2013-11-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 69,000 2,678,271 2.64 3.74 257,998 10,014,323
2013-12-02 2013-11-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 69,000 2,609,271 2.72 3.71 255,755 9,671,524
2013-12-02 2013-11-27 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 69,000 2,540,271 2.79 3.71 255,783 9,416,785
2013-06-13 2013-06-11 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 37,834 37,834
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift 15,015 2,471,271 0.61
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift 15,015 2,456,256 0.62
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift -90,090 2,441,241 -3.56
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift 39,000 2,531,331 1.56
2013-02-13 2012-12-19 5 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
G - Gift -39,000 2,492,331 -1.54
2012-12-17 2012-12-13 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 36,500 2,531,331 1.46 6.77 247,214 17,144,705
2012-09-18 2012-09-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 25,800 2,494,831 1.04 8.34 215,172 20,806,891
2012-09-18 2012-09-14 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 39,000 2,469,031 1.60 8.32 324,437 20,539,622
2012-08-27 2012-08-23 4 MACK MERRIMACK PHARMACEUTICALS INC
Stock Option (right to buy)
A - Award 31,600 31,600
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -450,000 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock
C - Conversion -22,000 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock
C - Conversion -22,000 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -23,300 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -23,300 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -28,332 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -28,332 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -21,429 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -21,429 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -79,000 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -79,000 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -35,714 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -184,975 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -300,000 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -30,000 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -15,863 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series G Convertible Preferred Stock
C - Conversion -313,266 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series F Convertible Preferred Stock
C - Conversion -41,900 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series E Convertible Preferred Stock
C - Conversion -46,676 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series D Convertible Preferred Stock
C - Conversion -463,654 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Series C Convertible Preferred Stock
C - Conversion -59,863 0 -100.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 450,000 2,430,031 22.73
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 22,000 1,980,031 1.12
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 22,000 1,980,031 1.12
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 23,300 1,958,031 1.20
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 23,300 1,958,031 1.20
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 28,332 1,934,731 1.49
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 28,332 1,934,731 1.49
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 21,429 1,906,399 1.14
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 21,429 1,906,399 1.14
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 79,000 1,884,970 4.37
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 79,000 1,884,970 4.37
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 35,714 1,631,909 2.24
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 184,975 1,596,195 13.11
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 300,000 1,411,220 27.00
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 30,000 1,111,220 2.77
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 15,863 1,081,220 1.49
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 313,266 1,065,357 41.65
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 41,900 752,091 5.90
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 46,676 710,191 7.03
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 463,654 663,515 231.99
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
C - Conversion 59,863 199,861 42.76
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 25,000 139,998 21.74 7.00 175,000 979,986
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 21,428 114,998 22.90 7.00 149,996 804,986
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 14,285 93,570 18.02 7.00 99,995 654,990
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 15,000 79,285 23.33 7.00 105,000 554,995
2012-04-05 2012-04-03 4 MACK MERRIMACK PHARMACEUTICALS INC
Common Stock
P - Purchase 64,285 64,285 7.00 449,995 449,995
P
Compra de mercado aberto ou privada de ativo não-derivativo ou derivativo
S
Venda de mercado aberto ou privada de ativo não-derivativo ou derivativo
A
Concessão, premiação, ou outra aquisição de ativos da empresa (como uma opção)
C
Conversão de derivativo
D
Venda ou transferência de ativos de volta para a empresa
F
Pagamento do preço de exercício ou responsabilidade fiscal utilizando parte dos ativos recebidos da empresa
G
Doação de ativos pelo ou para o insider
K
Swaps de capital e transações de hedge similares
M
Exercício ou conversão de ativo derivativo recebido da empresa (como uma opção)
V
Uma transação voluntariamente reportada no Formulário 4
J
Outro (acompanhado de uma nota explicativa descrevendo a transação)